Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
A modified FOXO4-p53 interfering peptide causes p53 nuclear exclusion, which can: Selectively induce apoptosis in senescent cells in vitro and in vivo Neutralize phenotypical and liver chemotoxicity by Doxorubicin Restore fitness, hair density and renal function in fast and naturally aged mice Acknowledgments We thank Felicity Chandler for assistance with IHC experiments, Anne Drabbe and David Brouwer for assistance with in vivo experiments, Yanto Ridwan for assistance with CT and IVIS imaging, Yvette van Loon for genotyping of the mice, Martin Viertler for initial NMR experiments, Boudewijn Burgering for fruitful discussions and Petra de Keizer-Burger for critical reading of the manuscript
doi: 10.1016/0014-5793(93)80858-r
In 2025, we saw [GLP-1] use expand well beyond type 2 diabetes, with growing attention to cardiometabolic outcomes/cardiovascular risk, arthritis, sleep apnea and liver disease
Rather than relying on temporary stimulants, Lipo B works at a deeper level to support cellular energy production
US$ 27.19
US$ 21.54
US$ 24.48
US$ 28.94